An Explorative Study of Afatinib in the Treatment of Advanced Cancer Carrying an EGFR, a HER2 or a HER3 Mutation

Clinical trial NCT03810872 · UNKNOWN

Trial details

NCT number: NCT03810872
Sponsor: Universitair Ziekenhuis Brussel
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Cancers Harbouring an EGFR Mutation, (Excluding Non-squamous Non- Small Cell Lung Cancer, a Registered Indication), a HER2 Mutation or a HER3 Mutation

Start date: 2017-06-21
Primary completion: 2020-12-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.